StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
259
This month
7
This week
1
This year
59
Yesterday
1
Publishing Date
2024 - 03 - 29
2
2024 - 03 - 22
2
2024 - 03 - 13
2
2024 - 03 - 11
2
2024 - 03 - 08
2
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
3
2024 - 01 - 22
2
2024 - 01 - 19
2
2024 - 01 - 17
3
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 12 - 19
2
2023 - 12 - 14
2
2023 - 12 - 07
2
2023 - 08 - 30
3
2023 - 05 - 31
2
2023 - 05 - 29
3
2023 - 05 - 03
2
2023 - 03 - 29
2
2022 - 12 - 09
2
2022 - 12 - 02
2
2022 - 09 - 30
3
2022 - 06 - 24
3
2022 - 05 - 20
3
2022 - 03 - 30
3
2022 - 03 - 28
2
2022 - 01 - 04
2
2021 - 10 - 08
3
2021 - 08 - 31
2
2021 - 08 - 19
2
2021 - 07 - 06
1
2021 - 07 - 02
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 02
1
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 14
1
2021 - 05 - 12
2
2021 - 05 - 10
1
2021 - 05 - 04
1
2021 - 04 - 29
1
2021 - 04 - 21
1
2021 - 04 - 12
1
2021 - 04 - 09
1
2021 - 04 - 08
1
2021 - 03 - 31
1
2021 - 03 - 26
1
2021 - 03 - 16
1
2021 - 03 - 12
1
2021 - 03 - 11
2
2021 - 03 - 10
1
Sector
Commercial services
5
Communications
1
Consumer durables
1
Consumer non-durables
6
Distribution services
10
Electronic technology
11
Finance
1
Health services
2
Health technology
259
Manufacturing
19
Mining, quarrying, and oil and gas extraction
1
N/a
6
Non-energy minerals
1
Process industries
2
Producer manufacturing
10
Professional, scientific, and technical services
1
Retail trade
1
Technology services
2
Tags
Antibiotics
4
Application
5
Approval
10
Approved
7
Astrazeneca
4
Biomarkers
3
Biotechnology
8
Blood
3
Cancer
9
Cardiac
3
Cardio
4
Cardiovascular
5
Covid
9
Covid-19
8
Device
17
Diabetes
3
Diagnostic
5
Diagnostics
5
Disease
11
Distribution
3
Drug
29
Drug delivery
4
Expansion
3
Expected
7
Eye
4
Fda
51
Fda-approvals
17
First
6
For
4
Global
53
Growing
3
Growth
40
Health
3
Hepatitis
3
Hiv
3
Hypertension
5
Impact
4
Implant
3
India
3
Infection
3
Iot
6
Keytruda
4
Liver
5
Market
98
Medical
5
N/a
184
News
10
People
7
Pharmaceutical
11
Rare
4
Reach
7
Regulatory
18
Report
43
Research
30
Schizophrenia
4
Therapeutics
7
Therapy
8
Travel
4
Treatment
23
Vaccine
4
Entities
3m company
54
Abbott laboratories
259
Abbvie inc.
162
Alkermes plc
25
Alphabet inc.
121
Amarin corporation plc
117
Amgen inc.
94
Arcturus therapeutics holdings inc.
32
Astellas pharma inc
26
Astrazeneca plc
117
Bausch health companies inc.
49
Baxter international inc.
43
Becton, dickinson and company
82
Biogen inc.
29
Boston scientific corporation
134
Bristol-myers squibb company
91
Cardinal health, inc.
22
Conmed corporation
56
Danaher corporation
19
Edgewell personal care
29
Eli lilly and company
175
Galapagos nv
43
Genmab a/s
57
Gilead sciences, inc.
43
Glaxosmithkline plc
191
Incyte corporation
22
Insulet corporation
21
Integra lifesciences holdings corporation
25
Intuitive surgical, inc.
20
Johnson & johnson
4583
Kenvue inc.
30
Kimberly-clark corporation
28
Koninklijke philips n.v.
53
Medtronic plc
211
Morgan stanley
26
Morphosys ag
122
Nektar therapeutics
121
Novartis ag
245
Novo nordisk a/s
44
Omnicom group inc.
21
Oncocyte corporation
118
Orange
26
Perrigo company
99
Pfizer, inc.
76
Ptc therapeutics, inc.
122
Rallybio corp
40
Royalty pharma plc
54
Sanofi
571
Smith & nephew plc
77
Stryker corporation
124
Takeda pharmaceutical company limited
82
Teleflex incorporated
28
Terumo corp
58
Teva pharmaceutical industries ltd
80
Therapeuticsmd, inc.
117
Thermo fisher scientific inc
33
Unilever plc
39
Vaxart, inc.
119
Viatris inc.
33
Zimmer biomet holdings, inc.
32
Symbols
A
43
AAPL
30
ABBV
61
ABCM
21
ABT
1787
ALPMF
21
ALPMY
21
AMGN
37
AZN
82
AZNCF
69
BAX
62
BDX
155
BIO
114
BMY
26
BSX
153
DGX
19
DHR
158
DXCM
22
EW
21
GE
31
GIFLF
19
GIKLY
18
GLAXF
110
GSK
128
HOLX
47
ILMN
48
JNJ
259
LH
29
LIVN
60
LLY
56
MDT
276
MMM
19
MYGN
19
NVO
20
NVS
119
NVSEF
105
PFE
32
PHG
78
PKI
35
PODD
24
PRGO
68
QDEL
74
QGEN
97
RBGLY
29
RBGPF
29
RYLPF
39
SNNUF
18
SNY
251
SNYNF
219
SYK
35
TEVJF
43
TFX
20
TMO
245
TRIB
23
TRUMF
60
TRUMY
60
UL
19
UNLYF
17
VIVO
17
VTRS
33
Exchanges
Amex
2
Nasdaq
191
Nyse
259
Crawled Date
2024 - 03 - 29
2
2024 - 03 - 22
2
2024 - 03 - 13
2
2024 - 03 - 11
2
2024 - 03 - 08
3
2024 - 02 - 29
2
2024 - 02 - 23
2
2024 - 02 - 15
2
2024 - 02 - 12
2
2024 - 02 - 02
2
2024 - 01 - 25
3
2024 - 01 - 22
2
2024 - 01 - 19
2
2024 - 01 - 17
3
2024 - 01 - 15
2
2024 - 01 - 03
2
2023 - 12 - 22
2
2023 - 12 - 07
2
2023 - 08 - 30
3
2023 - 06 - 01
2
2023 - 05 - 29
3
2023 - 03 - 29
2
2022 - 12 - 09
2
2022 - 12 - 02
2
2022 - 09 - 30
3
2022 - 06 - 24
3
2022 - 05 - 20
3
2022 - 03 - 30
3
2022 - 03 - 28
2
2022 - 01 - 04
2
2021 - 10 - 08
3
2021 - 08 - 19
2
2021 - 07 - 23
1
2021 - 07 - 22
1
2021 - 07 - 13
1
2021 - 07 - 07
1
2021 - 07 - 06
1
2021 - 07 - 02
1
2021 - 06 - 25
1
2021 - 06 - 23
1
2021 - 06 - 21
1
2021 - 06 - 17
1
2021 - 06 - 02
1
2021 - 06 - 01
1
2021 - 05 - 24
1
2021 - 05 - 14
1
2021 - 05 - 12
2
2021 - 05 - 10
1
2021 - 05 - 04
1
2021 - 04 - 29
1
2021 - 04 - 21
1
2021 - 04 - 12
1
2021 - 04 - 09
1
2021 - 04 - 08
1
2021 - 03 - 31
1
2021 - 03 - 26
1
2021 - 03 - 16
1
2021 - 03 - 12
1
2021 - 03 - 11
2
2021 - 03 - 10
1
Crawled Time
00:00
10
00:20
1
01:00
7
02:00
7
03:00
1
05:00
1
07:00
4
08:00
3
09:00
4
10:00
5
11:00
8
12:00
9
12:01
1
12:15
1
12:20
2
12:30
1
13:00
5
13:02
1
13:15
1
13:20
4
13:30
7
14:00
9
14:15
2
14:30
12
15:00
28
15:15
1
15:20
7
15:30
10
16:00
16
16:01
1
17:00
25
18:00
14
19:00
14
20:00
12
20:20
1
21:00
7
22:00
10
23:00
7
Source
www.biospace.com
75
www.globenewswire.com
2
www.prnewswire.com
182
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
entities :
Abbott laboratories
symbols :
JNJ
save search
Genentech’s ALK Inhibitor First Adjuvant Treatment for ALK-Positive, Early NSCLC
Published:
2024-04-19
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
2.53%
|
O:
-0.4%
H:
3.01%
C:
2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
2.04%
|
O:
0.83%
H:
1.35%
C:
1.2%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
0.83%
|
O:
-0.39%
H:
1.69%
C:
1.23%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
1.74%
|
O:
0.83%
H:
1.83%
C:
0.89%
first
treatment
for
AstraZeneca Wins Label Expansion for Severe Asthma Drug in Younger Kids
Published:
2024-04-12
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.53%
|
O:
-0.13%
H:
0.0%
C:
-2.94%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-1.85%
|
O:
-1.65%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.74%
|
O:
-1.06%
H:
0.21%
C:
-1.05%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.33%
|
O:
-3.02%
H:
0.0%
C:
0.0%
drug
label
astrazeneca
expansion
for
kids
Consumer Healthcare Market, 33% of Growth to Originate from North America, Technavio
Published:
2024-04-10
(Crawled : 18:00)
- prnewswire.com
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.64%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-2.48%
|
O:
-0.64%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.5%
|
O:
0.43%
H:
0.3%
C:
-0.18%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.28%
|
O:
0.05%
H:
0.0%
C:
0.0%
growth
Busy Weekend Sees Tumor-Agnostic Win for Enhertu, Another Rejection for Supernus
Published:
2024-04-08
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
0.01%
|
O:
2.24%
H:
0.0%
C:
-0.8%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.91%
|
O:
0.96%
H:
1.17%
C:
0.16%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-3.03%
|
O:
-0.48%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-3.53%
|
O:
0.09%
H:
0.16%
C:
-0.7%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-1.33%
|
O:
0.84%
H:
0.0%
C:
0.0%
for
FDA Greenlights New Antibiotic for SAB, Pneumonia
Published:
2024-04-05
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-3.54%
|
O:
-1.77%
H:
0.0%
C:
-1.81%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.07%
|
O:
-0.22%
H:
0.8%
C:
0.06%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.81%
|
O:
-1.84%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.57%
|
O:
-0.37%
H:
1.42%
C:
1.37%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.72%
|
O:
-3.44%
H:
0.0%
C:
0.0%
fda
for
FDA Approves Vanda Schizophrenia Drug for Bipolar I Disorder
Published:
2024-04-03
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.66%
|
O:
-0.29%
H:
1.34%
C:
-0.64%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.23%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.23%
|
O:
0.11%
H:
0.37%
C:
-0.77%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.94%
|
O:
0.69%
H:
0.0%
C:
0.0%
fda
drug
schizophrenia
AstraZeneca Kicks Off April With New PNH Approval
Published:
2024-04-02
(Crawled : 13:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-4.08%
|
O:
-1.09%
H:
0.13%
C:
-1.39%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.26%
|
O:
-0.77%
H:
0.8%
C:
0.74%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.29%
|
O:
-0.18%
H:
0.47%
C:
0.12%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.05%
|
O:
-1.14%
H:
0.02%
C:
-1.06%
approval
astrazeneca
Global Infectious Enteritis Treatment Market Report 2024: A USD$937.7 Million Market by 2034 - Antibiotics Segment Dominates the Market
Published:
2024-03-29
(Crawled : 23:00)
- prnewswire.com
ARDX
|
$6.5
0.93%
0.92%
5.6M
|
Health Technology
|
Email alert
Add to watchlist
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
News
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
News
|
$39.75
1.22%
0.0%
1.6M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
report
million
treatment
antibiotics
global
market
FDA Approves Treatments for Anemia in Chronic Kidney Disease, Hepatitis
Published:
2024-03-29
(Crawled : 19:00)
- biospace.com/
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
Email alert
Add to watchlist
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
Email alert
Add to watchlist
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
Email alert
Add to watchlist
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
Email alert
Add to watchlist
fda
hepatitis
kidney
anemia
FDA Approves New Treatments for Two Rare Diseases
Published:
2024-03-27
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-7.26%
|
O:
-0.26%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
0.0%
|
O:
0.84%
H:
1.48%
C:
1.29%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.96%
|
O:
0.3%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.86%
|
O:
1.48%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-5.89%
|
O:
1.06%
H:
0.0%
C:
0.0%
fda
rare
Regeneron Hit With Two CRLs, J&J’s PAH Treatment Approved
Published:
2024-03-25
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-1.09%
|
O:
-100.0%
H:
NaN%
C:
Infinity%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.66%
|
O:
0.35%
H:
0.35%
C:
-1.34%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.92%
|
O:
0.04%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-2.98%
|
O:
-0.07%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.68%
|
O:
0.42%
H:
0.0%
C:
0.0%
approved
treatment
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nods for DMD, Hypertension
Published:
2024-03-22
(Crawled : 15:00)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.21%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
Italfarmaco’s Duvyzat, Idorsia’s Tryvio Earn FDA Nod for DMD, Hypertension
Published:
2024-03-22
(Crawled : 14:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.65%
|
O:
-1.58%
H:
0.0%
C:
0.0%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-2.47%
|
O:
0.35%
H:
0.99%
C:
-1.17%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.9%
|
O:
0.02%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.21%
|
O:
-0.43%
H:
0.41%
C:
-0.85%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.44%
|
O:
1.47%
H:
0.23%
C:
-0.19%
fda
hypertension
FDA Approves Takeda’s Iclusig for Type of Leukemia, Idorsia’s Hypertension Drug
Published:
2024-03-21
(Crawled : 13:30)
- biospace.com/
SNYNF
|
News
|
$92.7
-2.18%
600K
|
Health Technology
|
-2.29%
|
O:
0.14%
H:
0.24%
C:
0.24%
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-1.6%
|
O:
0.0%
H:
1.6%
C:
0.89%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-4.93%
|
O:
-0.03%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-4.75%
|
O:
-0.56%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-2.16%
|
O:
0.3%
H:
0.0%
C:
0.0%
fda
drug
iclusig
hypertension
FDA Approves First Gene Therapy for Rare Pediatric Disease
Published:
2024-03-18
(Crawled : 23:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.42%
|
O:
0.33%
H:
0.13%
C:
-1.51%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.53%
|
O:
0.2%
H:
0.08%
C:
-1.14%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-5.41%
|
O:
1.71%
H:
0.36%
C:
-2.52%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.38%
|
O:
-0.81%
H:
0.0%
C:
0.0%
fda
rare
first
disease
therapy
Madrigal’s Rezdiffra, BMS’s Breyanzi Lead Week of Landmark FDA Approvals
Published:
2024-03-15
(Crawled : 15:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
-0.23%
|
O:
-0.62%
H:
0.59%
C:
-1.01%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.01%
|
O:
-1.58%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.64%
|
O:
-5.53%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.4%
|
O:
-0.02%
H:
0.0%
C:
0.0%
fda
breyanzi
week
Global Antidiabetics Market 10 Year Forecast Report 2024-2034, by Product Type, by Application, by Distribution Channel and Region
Published:
2024-03-13
(Crawled : 18:00)
- prnewswire.com
NVO
|
News
|
$122.71
-0.03%
0.17%
5M
|
Health Technology
|
-9.18%
|
O:
-0.64%
H:
0.94%
C:
-0.56%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
LLY
|
News
|
$726.31
-2.63%
-0.04%
3.5M
|
Health Technology
|
-3.79%
|
O:
0.27%
H:
0.5%
C:
0.11%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.73%
|
O:
0.41%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-4.22%
|
O:
-0.04%
H:
0.0%
C:
0.0%
report
distribution
year
global
market
Global Guidewires (Nitinol, Stainless Steel) Market Report 2024: A $2.03 Billion Market by 2029, Driven by Emerging Applications in Orthopaedics and Endoscopy, and Metallurgical Advancements
Published:
2024-03-13
(Crawled : 01:00)
- prnewswire.com
TRUMF
|
$16.928
-17.59%
1.9K
|
Health Technology
|
-57.27%
|
O:
-3.18%
H:
0.0%
C:
0.0%
TRUMY
|
$16.507
0.79%
34K
|
Manufacturing
|
-57.7%
|
O:
-1.29%
H:
0.39%
C:
0.39%
TFX
|
$206.56
-0.4%
0.0%
420K
|
Health Technology
|
-8.83%
|
O:
0.05%
H:
0.49%
C:
-1.99%
SYK
|
$325.43
-0.62%
0.0%
1.8M
|
Health Technology
|
-9.2%
|
O:
0.35%
H:
0.0%
C:
-0.76%
MDT
|
$79.48
0.37%
-0.29%
6.7M
|
Health Technology
|
-7.3%
|
O:
0.31%
H:
0.4%
C:
-1.08%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-8.36%
|
O:
0.66%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-10.73%
|
O:
0.41%
H:
0.0%
C:
0.0%
report
global
market
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug ...
Published:
2024-03-11
(Crawled : 17:00)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.82%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.94%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.18%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
FDA Decisions: Wegovy Approved for CV Indication; Viatris and Mapi’s MS Drug Rejected
Published:
2024-03-11
(Crawled : 14:30)
- biospace.com/
PRGO
|
News
|
$30.8
2.87%
-1.14%
1.2M
|
Health Technology
|
1.82%
|
O:
0.0%
H:
2.38%
C:
1.12%
JNJ
|
News
|
$147.91
1.49%
-0.03%
9.6M
|
Health Technology
|
-6.94%
|
O:
0.43%
H:
0.0%
C:
0.0%
ABT
|
News
|
$107.28
1.91%
0.18%
10M
|
Health Technology
|
-11.18%
|
O:
0.26%
H:
0.0%
C:
0.0%
SNY
|
News
|
$46.32
2.05%
2.01%
3.3M
|
Health Technology
|
-3.66%
|
O:
0.57%
H:
0.0%
C:
0.0%
fda
drug
wegovy
approved
← Previous
1
2
3
4
5
6
7
8
9
…
12
13
Next →
Gainers vs Losers
67%
33%
Top 10 Gainers
AGBA
|
News
|
$1.26
215.0%
68.25%
130M
|
Finance
EGOX
|
$0.0515
43.06%
30.1%
330M
|
OLB
4
|
$0.33
-14.95%
25.53%
840K
|
Technology Services
NVFY
|
$2.77
31.28%
23.83%
33M
|
Consumer Durables
ZCMD
|
$1.87
28.97%
22.46%
31M
|
Commercial Services
RCON
|
$0.1112
13.01%
21.28%
1.7M
|
Distribution Services
INSG
|
$3.03
25.21%
20.13%
330K
|
Electronic Technology
GCTK
|
$0.8191
22.25%
18.2%
190K
|
Manufacturing
WLGS
|
$0.59
18.0%
17.9%
2.3M
|
ASNS
|
$0.828
21.75%
17.86%
18K
|
Your saved searches
Save your searches and get alerts when important news are released.